Virpax Pharmaceuticals (VRPX) Quarterly EPS earnings growth

Virpax Pharmaceuticals - graphic logo of issuer VRPX

Virpax Pharmaceuticals (VRPX) develops analgesics through partnerships with scientific centers, as evidenced by the quarterly EPS growth rate, where the current parameter equals 89.90. The company is implementing innovative non-opioid drug delivery systems via the skin and mucous membranes. The development prospects for nasal platforms for pain management create long-term potential, while the market has already priced in the optimization of operating expenses.

Virpax Pharmaceuticals, Inc. (VRPX) - Year-over-year earnings per one share growth for the last 12 months from 07/04/2022 to 04/13/2025

Financial and market metric breakdowns for virpaxpharma.com (VRPX)

- share price and consensus valuation forecast:
Analysis of all company metrics:Virpax Pharmaceuticals
Finished products of Virpax Pharmaceuticals

Quarterly EPS growth measures the dynamics of net profit per share, reflecting capital management efficiency and the business's operational performance over a three-month period. For Virpax Pharmaceuticals (VRPX), this metric demonstrates how successfully the development of innovative delivery systems for non-opioid analgesics translates into financial results, allowing quarterly EPS growth to assess the resilience of investments against market volatility.

Who Virpax Pharmaceuticals competes with

ALKS (alkermes.com) - Year-over-year net earnings per share growth for the last 12 months|Earnings per share growth in annualized terms for the last twelve months Avadel Pharma (AVDL)|ATAI (atai.life) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months GH Research PLC (GHRS)|Quarterly EPS earnings growth MNMD|CMPS (COMPASS Pathways PLC) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months lbpharma.us LBRX|Bright Minds Biosciences Inc (DRUG) - Earnings per share growth in annualized terms for the last twelve months|VNDA: Year-over-year net earnings per share growth for the last 12 months|Cybin Inc (CYBN) - Year-over-year net earnings per share growth for the last 12 months|Alto Neuroscience (ANRO) - Year-over-year earnings per share growth for the last twelve months|NRx Pharma - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Cingulate|Year-over-year earnings per share growth for the last twelve months SILO|Year-over-year earnings per share growth for the last twelve months China Pharma (CPHI)|Quarterly EPS earnings growth Clearmind Medicine, Inc. (CMND)|Quarterly EPS earnings growth PBM (Psyence Biomedical Ltd)|SPRC (SciSparc) - Year-over-year net earnings per share trend for the last twelve months|SEEL - Year-over-year earnings per share growth for the last twelve months|KRTX - Quarterly EPS earnings growth